1 - 25 of 29 results for author:"Huizinga E.G." in Literature citations
Results Customize
› Repeat search in UniProtKB (17)
| Formation and structure of a NAIP5-NLRC4 inflammasome induced by direct interactions with conserved N- and C-terminal regions of flagellin. Halff E.F., Diebolder C.A., Versteeg M., Schouten A., Brondijk T.H., Huizinga E.G. J. Biol. Chem. 287:38460-38472(2012) · Mapped (15) |
| Evasion of Toll-like receptor 2 activation by staphylococcal superantigen-like protein 3. Bardoel B.W., Vos R., Bouman T., Aerts P.C., Bestebroer J., Huizinga E.G., Brondijk T.H., van Strijp J.A., de Haas C.J. J. Mol. Med. 90:1109-1120(2012) · Mapped (1) |
| Implications for collagen I chain registry from the structure of the collagen von Willebrand factor A3 domain complex. Brondijk T.H., Bihan D., Farndale R.W., Huizinga E.G. Proc. Natl. Acad. Sci. U.S.A. 109:5253-5258(2012) · Mapped (1) |
| Calcium modulates force sensing by the von Willebrand factor A2 domain. Jakobi A.J., Mashaghi A., Tans S.J., Huizinga E.G. Nat Commun 2:385-385(2011) · Mapped (1) |
| Crystal structure and collagen-binding site of immune inhibitory receptor LAIR-1: unexpected implications for collagen binding by platelet receptor GPVI. Brondijk T.H., de Ruiter T., Ballering J., Wienk H., Lebbink R.J., van Ingen H., Boelens R., Farndale R.W., Meyaard L., Huizinga E.G. |
| Structural basis for ligand and substrate recognition by torovirus hemagglutinin esterases. Langereis M.A., Zeng Q., Gerwig G.J., Frey B., von Itzstein M., Kamerling J.P., de Groot R.J., Huizinga E.G. Proc. Natl. Acad. Sci. U.S.A. 106:15897-15902(2009) · UniProtKB (1) · Mapped (1) |
| Fifteen novel mutations in PKLR associated with pyruvate kinase (PK) deficiency: structural implications of amino acid substitutions in PK. van Wijk R., Huizinga E.G., van Wesel A.C.W., van Oirschot B.A., Hadders M.A., van Solinge W.W. |
| Crystal structures of TAFI elucidate the inactivation mechanism of activated TAFI: a novel mechanism for enzyme autoregulation. Marx P.F., Brondijk T.H., Plug T., Romijn R.A., Hemrika W., Meijers J.C., Huizinga E.G. Blood 112:2803-2809(2008) · UniProtKB (1) |
| Structure of coronavirus hemagglutinin-esterase offers insight into corona and influenza virus evolution. Zeng Q., Langereis M.A., van Vliet A.L., Huizinga E.G., de Groot R.J. Proc. Natl. Acad. Sci. U.S.A. 105:9065-9069(2008) · UniProtKB (1) |
| Factor B structure provides insights into activation of the central protease of the complement system. Milder F.J., Gomes L., Schouten A., Janssen B.J., Huizinga E.G., Romijn R.A., Hemrika W., Roos A., Daha M.R., Gros P. Nat. Struct. Mol. Biol. 14:224-228(2007) · Mapped (3) |
| Structure of complement component C2A: implications for convertase formation and substrate binding. Milder F.J., Raaijmakers H.C., Vandeputte M.D., Schouten A., Huizinga E.G., Romijn R.A., Hemrika W., Roos A., Daha M.R., Gros P. Structure 14:1587-1597(2006) · Mapped (1) |
| A single high-affinity binding site for von Willebrand factor in collagen III, identified using synthetic triple-helical peptides. Lisman T., Raynal N., Groeneveld D., Maddox B., Peachey A.R., Huizinga E.G., de Groot P.G., Farndale R.W. Blood 108:3753-3756(2006) |
| Characterization of bitiscetin-2, a second form of bitiscetin from the venom of Bitis arietans: comparison of its binding site with the collagen-binding site on the von Willebrand factor A3-domain. Obert B., Romijn R.A., Houllier A., Huizinga E.G., Girma J.P. J. Thromb. Haemost. 4:1596-1601(2006) · UniProtKB (1) |
| Paratope determination of the antithrombotic antibody 82D6A3 based on the crystal structure of its complex with the von Willebrand factor A3-domain. Staelens S., Hadders M.A., Vauterin S., Platteau C., De Maeyer M., Vanhoorelbeke K., Huizinga E.G., Deckmyn H. J. Biol. Chem. 281:2225-2231(2006) · Mapped (8) |
| Structures of complement component C3 provide insights into the function and evolution of immunity. Janssen B.J.C., Huizinga E.G., Raaijmakers H.C.A., Roos A., Daha M.R., Nilsson-Ekdahl K., Nilsson B., Gros P. |
| Distinct phenotypic expression of two de novo missense mutations affecting the dimer interface of glucose-6-phosphate dehydrogenase. van Wijk R., Huizinga E.G., Prins I., Kors A., Rijksen G., Bierings M., van Solinge W.W. Blood Cells Mol. Dis. 32:112-117(2004) · Mapped (7) |
| An experimental model to study the in vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutation. Lenting P.J., Westein E., Terraube V., Ribba A.-S., Huizinga E.G., Meyer D., de Groot P.G., Denis C.V. J. Biol. Chem. 279:12102-12109(2004) · UniProtKB (1) · Mapped (7) |
| Mapping the collagen-binding site in the von Willebrand factor-A3 domain. Romijn R.A., Westein E., Bouma B., Schiphorst M.E., Sixma J.J., Lenting P.J., Huizinga E.G. J. Biol. Chem. 278:15035-15039(2003) · Mapped (6) |
| HK Utrecht: missense mutation in the active site of human hexokinase associated with hexokinase deficiency and severe nonspherocytic hemolytic anemia. van Wijk R., Rijksen G., Huizinga E.G., Nieuwenhuis H.K., van Solinge W.W. Blood 101:345-347(2003) · UniProtKB (1) |
| Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain. Huizinga E.G., Tsuji S., Romijn R.A., Schiphorst M.E., de Groot P.G., Sixma J.J., Gros P. |
| Crystal structure of quinohemoprotein alcohol dehydrogenase from Comamonas testosteroni: structural basis for substrate oxidation and electron transfer. Oubrie A., Rozeboom H.J., Kalk K.H., Huizinga E.G., Dijkstra B.W. J. Biol. Chem. 277:3727-3732(2002) · UniProtKB (1) |
| Crystallization of quinohaemoprotein alcohol dehydrogenase from Comamonas testosteroni: crystals with unique optical properties. Oubrie A., Huizinga E.G., Rozeboom H.J., Kalk K.H., de Jong G.A.H., Duine J.A., Dijkstra B.W. Acta Crystallogr. D 57:1732-1734(2001) · UniProtKB (1) |
| The structure of leech anti-platelet protein, an inhibitor of haemostasis. Huizinga E.G., Schouten A., Connolly T.M., Kroon J., Sixma J.J., Gros P. Acta Crystallogr. D 57:1071-1078(2001) · UniProtKB (1) |
| Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency. van Wijk R., Nieuwenhuis K., van den Berg M., Huizinga E.G., van der Meijden B.B., Kraaijenhagen R.J., van Solinge W.W. Blood 98:358-367(2001) · UniProtKB (1) |
| Identification of the collagen-binding site of the von Willebrand factor A3-domain. Romijn R.A., Bouma B., Wuyster W., Gros P., Kroon J., Sixma J.J., Huizinga E.G. J. Biol. Chem. 276:9985-9991(2001) · Mapped (2) |